JKI 22 Pill - beige oval, 11mm
Generic Name: tofacitinib
Pill with imprint JKI 22 is Beige, Oval and has been identified as Xeljanz XR 22 mg. It is supplied by Pfizer Inc.
Xeljanz XR is used in the treatment of Ankylosing Spondylitis; Rheumatoid Arthritis; Psoriatic Arthritis; Ulcerative Colitis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz XR 22 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for JKI 22
Xeljanz XR
- Generic Name
- tofacitinib
- Imprint
- JKI 22
- Strength
- 22 mg
- Color
- Beige
- Size
- 11.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0502
More about Xeljanz XR (tofacitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (17)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.